Search

The pharmaceutical company ViiV Healthcare has been the leader in developing potent dual-drug HIV regimens, such as the following: . Juluca – a pill ...

Dolutegravir belongs to a class of anti-HIV drugs called integrase inhibitors. In Canada and other high-income countries, dolutegravir is sold in the following ...

Scientists conducted a randomized study of ketamine and mindfulness. Results appear promising as some people were able to stop using cocaine. More research lies ...

Scientists in B.C. mapped the flow of patients from hepatitis C diagnosis to cure. At each stage of the cascade, some patients did not progress to the next step ...

Researchers evaluated an online testing service for sexually transmitted infections. The B.C. program offers direct access to testing through online lab ...

Post-exposure prophylaxis (PEP) can prevent HIV if initiated within 72 hours. Some Toronto clinicians prescribed PEP in advance to reduce delays in initiation. ...

...

Researchers compared the health of HIV-positive and HIV-negative women. Women with HIV were nearly 60% more likely to have another health condition  . ...

Frailty can sometimes occur early in HIV-positive people. In a recent study, frailty was linked to an increased risk for heart disease and diabetes. Research ...

80% of people with HIV used cannabis at least once weekly, mostly through smoking. The top reported reason was pleasure, followed by stress and anxiety ...

Integrating hepatitis C care into an overdose prevention service.

Access to self-test kits increased HIV testing rates among men who have sex with men. More cases of HIV were diagnosed among study participants offered ...